Virus entry: molecular mechanisms and biomedical applications.
about
Actin-binding protein drebrin regulates HIV-1-triggered actin polymerization and viral infectionFunctional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosisThe SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterizationCell Culture, Technology: Enhancing the Culture of Diagnosing Human DiseasesInteraction of bacteriophage l with its E. coli receptor, LamBViral Membrane Channels: Role and Function in the Virus Life CycleCytoplasmic fungal lipases release fungicides from ultra-deformable vesicular drug carriersConformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusionDifferences in the postfusion conformations of full-length and truncated class II fusion protein E of tick-borne encephalitis virus.Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the NucleusVaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansHost cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3Arms Race between Enveloped Viruses and the Host ERAD MachineryPoxvirus tropismMembrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of actionMolecular engineering of polymersome surface topologyA Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections.Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery.Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stabilityEnergetic cost of building a virus.Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodySperm-egg fusion: a molecular enigma of mammalian reproduction.Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins.Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.Clinical development of monoclonal antibody-based drugs in HIV and HCV diseasesGangliosides are essential for bovine adeno-associated virus entry.Targeting lentiviral vectors to specific cell types in vivo.Identification of novel viral receptors with cell line expressing viral receptor-binding protein.Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane "fusogen"Single-virus tracking reveals a spatial receptor-dependent search mechanism.Entry of tiger frog virus (an Iridovirus) into HepG2 cells via a pH-dependent, atypical, caveola-mediated endocytosis pathwayEnhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugatesVirus-engineered colloidal particles--a surface display system.Integrin alphavbeta3 is a coreceptor for human cytomegalovirus.
P2860
Q24316027-31BE709F-F0EA-46FA-B480-E3B80457A1DCQ24674137-2938B5C5-0AF9-439E-AC86-913D15487881Q24817089-12776B8C-0DB6-4151-B508-5AABDB79E110Q26748487-3999A864-65CB-4C16-8056-14F57069BD84Q26862248-4FD5F194-989D-431C-AB51-B3A7E0B41530Q27000898-F7E9992F-D40A-42F4-A304-68AE6D89EA5AQ27301805-F1BB6246-B30D-42E3-A81A-EF42A1960A6CQ27302420-17D7C7D9-27E6-415F-B92D-DE353296B605Q27469513-0C0CCE74-06E1-44E2-ABAE-B31170C94D70Q27488284-90A05BB8-99CF-41B5-8820-D39DA486D1F8Q27488704-CE7B67D6-EB2B-42EC-9F8A-1C7D7AB671A8Q27651214-72B4237C-0143-4275-B5CF-C5ECBF26C1B5Q28078319-2FFB76EB-1F74-44FC-A367-534394ACC100Q28237434-EB0761A0-D93D-46DA-8C19-0E09B0A5DA5FQ28475682-81894959-87EC-4A4F-A734-39A7AFC47213Q28834130-345DB732-347F-4F87-BB97-9542813CE816Q30378994-EB473F79-A332-4E77-B529-F1AE799DF6C8Q30447936-290A6AC6-761D-487E-A3D3-7B50FC4D91E8Q30788662-7733C9BF-1923-4A46-BF41-82671F853A99Q30805028-4D5629E7-A0F9-4105-89F0-3FDDF93700B8Q33239031-E0C65E0C-4815-4BA0-A9EE-238AC8A40089Q33262382-2E13C3AA-1A23-4826-B20D-D20B73BF6BD7Q33413784-07F6F80A-B672-459F-B2B7-0B2F5268A157Q33622464-1EC931F3-5F25-486B-B26F-9372C60DADA7Q33782563-8EA3F4C4-F41E-4EFD-92F8-BD162D513052Q33788855-B0667F2F-E232-45CA-AB0B-F651D46CC572Q33897964-5A59E82F-0932-42C1-BAC0-3FDFD99C006EQ33907846-CE50F7C6-7F90-4BC7-BE3C-8E0B84CE8CFBQ34091383-63AE6D53-275E-4319-86CB-3A15BF14DD35Q34281656-24B3E369-4A61-4EAA-ABB4-B50169D29AEDQ34536782-AAF4CE9C-1A1E-433C-8397-EF9F509ED1C5Q34648299-BAEBBF6E-0D4F-4C68-9C94-A5BF5AB75F0DQ34830842-B8BEB31F-A625-46C5-9FAD-19C3A4F07CD6Q34990603-8F10380B-5179-4921-B009-3715522C55F0Q35021457-E24D6EF2-1E7B-4D7F-8FD7-650F9CEFB09CQ35070497-26BB2630-5315-4CF2-8F60-66F3644B2963Q35077445-9E862D9C-C3A9-4960-83FF-EAC73AA1433AQ35094530-2F9AD889-F285-4241-A994-908677589123Q35232647-0EF80001-71AC-41C7-AB00-AEF76A38D765Q35865693-1EFFF8F1-7706-4FAB-B487-A398E1E92529
P2860
Virus entry: molecular mechanisms and biomedical applications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Virus entry: molecular mechanisms and biomedical applications.
@ast
Virus entry: molecular mechanisms and biomedical applications.
@en
type
label
Virus entry: molecular mechanisms and biomedical applications.
@ast
Virus entry: molecular mechanisms and biomedical applications.
@en
prefLabel
Virus entry: molecular mechanisms and biomedical applications.
@ast
Virus entry: molecular mechanisms and biomedical applications.
@en
P2860
P356
P1476
Virus entry: molecular mechanisms and biomedical applications.
@en
P2093
Dimiter S Dimitrov
P2860
P2888
P304
P356
10.1038/NRMICRO817
P407
P577
2004-02-01T00:00:00Z